This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 16 Apr 2013  |  Asia Pacific  |  Market Research

    Analysis of the Asia-Pacific Molecular Diagnostics Market

    This Market Engineering research services is to analyze and evaluate the molecular diagnostics market in the Asia-Pacific region. This research covers four segments, namely infectious diseases, genetic diseases, oncology, and pharmacogenomics. It provides insights and analysis on current and future trends, market drivers, market restraints, revenue...

    $4,950.00
  2. 10 Apr 2013  |  North America  |  Market Research

    Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market

    New Growth Opportunities Emerge in a Mature Market

    This research service pertains to the US market for interventional x-ray equipment used in radiology and cardiology. A thorough market sizing and forecasting model of market revenue, unit shipments, and pricing is included, along with analyses of technology trends, market drivers and restraints, and the competitive environment. The two market segme...

    $4,950.00
  3. 09 Apr 2013  |  Global  |  Market Research

    The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?

    European Biopharmaceutical Contract Manufacturing Market

    This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.

    $1,500.00
  4. 05 Apr 2013  |  Europe  |  Market Research

    Market Trends in Interventional Radiology and Cardiology in Europe

    The Future is in Hybrid Systems

    This research service provides an analysis of various aspects of the interventional radiology and cardiology market in Europe between 2011 and 2017. The study covers twelve countries and regions: Benelux, Bulgaria, the Czech Republic, France, Germany, Hungary, Italy, Poland, Romania, Scandinavia, Spain and the United Kingdom. A detailed analysis of...

    $4,950.00
  5. 04 Apr 2013  |  North America  |  Market Research

    U.S. qPCR Reagents Market

    Finding Opportunities in a Changing Competitive and Patent Landscape

    This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due to a period of patent expirations, competitive expansion, and pricing pressure. This research service offers a discussion of the key market drivers and restraints, a detailed analysis of the changing competitive lands...

    $4,950.00
  6. 28 Mar 2013  |  Latin America  |  Market Research

    Brazilian Medical Imaging Market Outlook for CT, MRI, and Ultrasound

    Governmental Programs and Investments Stimulate the Market

    This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...

    $10,000.00
  7. 28 Mar 2013  |  North America  |  Market Research

    Vital Signs - The Healthcare News - March Issue

    This issue of Vital Signs, released on March 28, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.

    $1,500.00
  8. 27 Mar 2013  |  Africa  |  Market Research

    Healthcare Infrastructure: Market for New and Revitalized Hospitals in Kenya

    Analysis of Investment Trends and Opportunities

    The aim of this research service was to provide insight into the market for revitalization and construction of new hospitals in the country and in addition quantify this market. This research service provides a detailed overview of the structure of the public and private hospital sector in Kenya. An overview of the healthcare structure as well as h...

    $1,500.00
  9. 26 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    $1,500.00
  10. 21 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Anti-obesity Prescription Drug Development

    Recent Marketing Approvals Revive Hope for Successful Treatment Options

    This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...

    $1,500.00